Biologic characteristics and treatment of acute nonlymphocytic leukemia in children

B. C. Lampkin, B. Lange, I. Bernstein, W. Woods, L. Odom, R. Wells, F. Ruymann, S. Feig, L. Miller, R. Chard, D. Benjamin, J. Buckley, T. Kim, D. Hammond

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Abstract

Major advances in the treatment of children with ANLL have occurred during the past 15 years. Today, approximately 75 per cent of patients will enter a complete remission, and about 40 per cent will have an event-free survival for over 3 years irrespective of whether they received a bone marrow transplant or chemotherapy after induction. A number of biologic characteristics of ANLL cells have been defined, but only three are clearly recognized in children today to have an impact on prognosis. These are a WBC greater than 100,000, monoblastic leukemia in infants less than 2 years of age, and certain chromosomal abnormalities.

Original languageEnglish (US)
Pages (from-to)743-764
Number of pages22
JournalPediatric Clinics of North America
Volume35
Issue number4
DOIs
StatePublished - 1988

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Fingerprint

Dive into the research topics of 'Biologic characteristics and treatment of acute nonlymphocytic leukemia in children'. Together they form a unique fingerprint.

Cite this